Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 20(5):385–397

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su D, Cui Y, He C, Yin P, Bai R, Zhu J et al (2025) Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952

Article  PubMed  PubMed Central  Google Scholar 

Munhoz RP, Tumas V, Pedroso JL, Silveira-Moriyama L (2024) The clinical diagnosis of Parkinson’s disease. Arq Neuropsiquiatr 82(6):1–10

PubMed  Google Scholar 

Min X, Zhou W, Fan X (2023) Risk factors for Parkinson’s disease in aging population. Asian J Surg 46(10):4413–4415

Article  PubMed  Google Scholar 

Nott A, Holtman IR (2023) Genetic insights into immune mechanisms of Alzheimer’s and Parkinson’s disease. Front Immunol 14:1168539

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T-W, Chen C-M, Chang K-H (2022) Biomarker of neuroinflammation in Parkinson’s Disease. Int J Mol Sci 23(8):4148

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heidari A, Yazdanpanah N, Rezaei N (2022) The role of toll-like receptors and neuroinflammation in Parkinson’s disease. J Neuroinflammation 19(1):135

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, Luciano MS, Tanner C (2024) The epidemiology of Parkinson’s disease. Lancet (London, England) 403(10423):283–292

Article  PubMed  Google Scholar 

Gan Y-H, Ma L-Z, Zhang Y, You J, Guo Y, He Y et al (2025) Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers. Nat Aging 5(4):642–657

Article  CAS  PubMed  Google Scholar 

Vishnoi A, Rani S (2023) MiRNA biogenesis and regulation of diseases: an updated overview. Methods in Molecular Biology (Clifton, NJ) 2595:1–12

Article  CAS  Google Scholar 

Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR, Tavakol-Afshari J (2024) MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease. Biomed Pharmacother 177:116899

Article  CAS  PubMed  Google Scholar 

Duan X, Zheng Q, Liang L Zhou L (2024) Serum exosomal miRNA-125b and miRNA-451a are potential diagnostic biomarker for Alzheimer's diseases. Degener Neurol Neuromuscul Dis 14:21–31

Mohammadinasr M, Montazersaheb S, Ayromlou H, Hosseini V, Molavi O, Hejazi MS (2024) Exosome content-mediated signaling pathways in multiple sclerosis. Mol Neurobiol 61(8):5404–5417

Article  CAS  PubMed  Google Scholar 

Mohammadinasr M, Montazersaheb S, Hosseini V, Kahroba H, Talebi M, Molavi O et al (2024) Epstein-barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients. Cytokine

Article  PubMed  Google Scholar 

Kim K-H, Hong EP, Lee Y, McLean ZL, Elezi E, Lee R et al (2024) Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington’s disease. Proc Natl Acad Sci U S A 121(16):e2322924121

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shaheen N, Shaheen A, Osama M, Nashwan AJ, Bharmauria V, Flouty O (2024) Micrornas regulation in Parkinson’s disease, and their potential role as diagnostic and therapeutic targets. NPJ Parkinsons Dis 10(1):186

Article  PubMed  PubMed Central  Google Scholar 

Hwang JS, Kim SG, George NP, Kwon M, Jang YE, Lee SS et al (2024) Biological function analysis of microRNAs and proteins in the cerebrospinal fluid of patients with Parkinson’s disease. Int J Mol Sci 25(24):13260

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santos-Lobato BL, Vidal AF, Ribeiro-Dos-Santos  (2021) Regulatory miRNA-mRNA networks in Parkinson’s disease. Cells 10(6):1410

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang X, Zhang M, Wei M, Wang A, Deng Y, Cao H (2020) Microrna-216a inhibits neuronal apoptosis in a cellular Parkinson’s disease model by targeting Bax. Metab Brain Dis 35(4):627–635

Article  PubMed  Google Scholar 

Zhang L, Chen X, Chang M Jiao B (2021) MiR-30c-5p/ATG5 Axis Regulates the Progression of Parkinson's Disease. Front Cell Neurosci 15:644507

Shukla S, Goyani S, Chakraborty D, Saranga MV, Mane M, Chandak N et al (2025) hsa-miR-22-3p-Mediated exosome release from neurons induces apoptosis in recipient glial and neuronal cells in parkinson’s disease stress conditions. Eur J Neurosci 62(10):e70342

Article  CAS  PubMed  Google Scholar 

Vaheb Hosseinabadi S, Tahamtan H, Mahmoudian Esfahani M, Ghaedi-Heidari R, Hashemi M-S, Peymani M et al (2025) Upregulation of miR-361-5p attenuates MPP+-induced neurotoxicity in dopaminergic SH-SY5Y cells as Parkinson’s disease model. J Biol Chem 301(12):110912

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S et al (2018) Aging and Parkinson’s disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med 115:80–91

Article  CAS  PubMed  Google Scholar 

Saadh MJ, Muhammad FA, Singh A, Mustafa MA, Al Zuhairi RAH, Ghildiyal P et al (2025) MicroRNAs modulating neuroinflammation in Parkinson’s disease. Inflammation 48(3):1042–1062

Article  CAS  PubMed  Google Scholar 

Moradi Vastegani Z, Ghaedi-Heidari R, Oroujalian A, Peymani M, Ghaedi K (2025) Manuscript title: unravelling the neuroprotective role of miR-27a-3p in the MAPK pathway in Parkinson’s disease. Metab Brain Dis 40(3):141

Article  CAS  PubMed  Google Scholar 

Mao Y, Shen J, Wu Y, Wenjing R, Zhu F, Duan S (2022) Aberrant expression of microrna-4443 (miR-4443) in human diseases. Bioengineered 13(6):14770–14779

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, Lu G, Wang D, He JL, Zuo L, Wang H et al (2020) MicroRNA-4443 regulates monocyte activation by targeting tumor necrosis factor receptor associated factor 4 in stroke-induced immunosuppression. Eur J Neurol 27(8):1625–1637

Article  CAS  PubMed  Google Scholar 

Qi Y, Zhou Y, Chen X, Ye L, Zhang Q, Huang F et al (2017) MicroRNA-4443 causes CD4+ T cells dysfunction by targeting TNFR-Associated factor 4 in Graves’ disease. Front Immunol 8:1440

Article  PubMed  PubMed Central  Google Scholar 

Ge X, Yao T, Zhang C, Wang Q, Wang X, Xu L-C (2022) Human microRNA-4433 (hsa-miR-4443) targets 18 genes to be a risk factor of neurodegenerative diseases. Curr Alzheimer Research. 19(7):511–522

Article  CAS  Google Scholar 

Salemi M, Marchese G, Lanza G, Cosentino FII, Salluzzo MG, Schillaci FA et al (2022) Role and dysregulation of miRNA in patients with Parkinson’s disease. Int J Mol Sci 24(1):712

Article  PubMed  PubMed Central  Google Scholar 

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601

Article  PubMed  Google Scholar 

Lin X, Wang R, Li R, Tao T, Zhang D, Qi Y (2022) Diagnostic performance of miR-485–3p in patients with Parkinson’s Disease and its Relationship with Neuroinflammation. Neuromolecular Medicine. 24(2):195–201

Article  CAS  PubMed